(Q40724926)

23 September 2017

Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines (English)

1 reference

23 September 2017

Haval Shirwan

1

1 reference

23 September 2017

Rajesh K Sharma

series ordinal

2

1 reference

23 September 2017

Abhishek K Srivastava

series ordinal

3

1 reference

23 September 2017

Esma S Yolcu

series ordinal

4

1 reference

23 September 2017

language of work or name

1 reference

1 April 2013

1 reference

23 September 2017

1 reference

23 September 2017

2

1 reference

23 September 2017

4

1 reference

23 September 2017

e23440

1 reference

Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner

23 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

The role of TNF superfamily members in T-cell function and diseases

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

Eradication of established tumors in mice by a combination antibody-based therapy

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3654576

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23734306

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.23440

1 reference

release_zn7eas5eavbnlnuqrka7cijcoy

23 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zn7eas5eavbnlnuqrka7cijcoy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 September 2017

PubMed publication ID

23734306

1 reference